close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunocore Holdings plc - American Depositary Shares (NQ:IMCR)

30.34 -1.30 (-4.12%)
Delayed Quote Updated: 2:30 PM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Immunocore Holdings plc - American Depositary Shares

< Previous 1 2 3 4 Next >
News headline image
Immunocore Q2 Earnings Call Highlights ↗
Immunocore (NASDAQ:IMCR) reported continued growth for KIMMTRAK in the second quarter and first half of 2026, while advancing three late-stage melanoma trials and early-stage programs in oncology, HIV... 
Via MarketBeat
Topics Earnings
Immunocore (NASDAQ:IMCR) Q2 Revenue Beats but EPS Misses, Shares Tumble ↗
Via Chartmill
News headline image
Immunocore (IMCR) Q4 2025 Earnings Call Transcript ↗
Immunocore (IMCR) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Immunocore (IMCR) Q2 2025 Earnings Call Transcript ↗
Immunocore (IMCR) Q2 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Demystifying Immunocore Holdings: Insights From 9 Analyst Reviews ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Immunocore Hldgs Stock ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 26, 2025 ↗
 
Via Benzinga
News headline image
Growth Picks: 3 Low-Cost Stocks That Could Double in Value ↗
Via MarketBeat
News headline image
Immunocore (IMCR) Q2 Revenue Jumps 30% ↗
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Immunocore Holdings PLC (NASDAQ:IMCR) Beats Q2 2025 Revenue and EPS Estimates with Strong KIMMTRAK Sales Growth ↗
Immunocore (IMCR) beat Q2 2025 estimates with $98M revenue (+30% YoY) and a narrower EPS loss. KIMMTRAK sales surged 32%, while pipeline progress and strong cash position ($882.8M) boosted investor... 
Via Chartmill
News headline image
Analyst Expectations For Immunocore Holdings's Future ↗
 
Via Benzinga
News headline image
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Analyst Expectations For Immunocore Hldgs's Future ↗
 
Via Benzinga
News headline image
Navigating 8 Analyst Ratings For Immunocore Hldgs ↗
 
Via Benzinga
News headline image
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday? ↗
Morgan Stanley downgrades Amicus Therapeutics, Immunocore, and Immuneering, citing pricing challenges, pipeline updates, and cautious growth outlooks. 
Via Benzinga
News headline image
3 Fast-Growing Stocks Analysts See Doubling in Price
Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches. 
Via MarketBeat
News headline image
A Closer Look at 9 Analyst Recommendations For Immunocore Hldgs ↗
 
Via Benzinga
News headline image
Analyst Ratings For Immunocore Hldgs ↗
 
Via Benzinga
News headline image
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Analyst Expectations For Immunocore Hldgs's Future ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings For Immunocore Hldgs ↗
 
Via Benzinga
News headline image
Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings) ↗
 
Via Benzinga
News headline image
3 Small-Cap Stocks with Significant Growth Potential ↗
As sector rotation continues, it could be time for investors to consider these small-cap growth stocks that institutions love. 
Via InvestorPlace
News headline image
Peeling Back The Layers: Exploring Immunocore Hldgs Through Analyst Insights ↗
 
Via Benzinga
News headline image
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Analyst Expectations For Immunocore Hldgs's Future ↗
 
Via Benzinga
News headline image
Where Immunocore Hldgs Stands With Analysts ↗
 
Via Benzinga
News headline image
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
IMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024 ↗
IMCR stock results show that Immunocore Hldgs missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.